|
1 Dec 2004
|
IDEXX Laboratories acquires Bommeli Diagnostics [Trade]
Intervet herewith publishes a press release by IDEXX Laboratories Inc. acquiring Dr. Bommeli AG, an Intervet company.WESTBROOK, Maine, December 1, 2004—IDEXX Laboratories, Inc. (NASDAQ: IDXX), announced ...
|
|
23 Aug 2004
|
IDEXX Laboratories to purchase Bommeli Diagnostics
Intervet herewith publishes a press release by IDEXX Laboratories Inc. purchasing Dr. Bommeli AG, an Intervet company.WESTBROOK, Maine, TBD, 2004-08-23—The Production Animal Services group of IDEXX Laboratories, ...
|
|
21 Jun 2004
|
Intervet India Commended For Its Commitment
Boxmeer, the Netherlands, June 18, 2004 – Last week, Intervet India received the Holland Award for its 'outstanding achievements in the field of International Agri-business in India and the Animal Health ...
|
|
21 Jun 2004
|
Intervet India Commended For Its Commitment (Dutch version)
Boxmeer, 18 juni 2004 – Vorige week heeft Intervet India de Holland Award voor ‘uitstekende prestaties op het gebied van internationale landbouw in India en diergezondheid’ uitgereikt gekregen. Directeur ...
|
|
3 May 2004
|
Feed Additives Business transferred to Intervet
Boxmeer/Stenungsund, May 3, 2004 - In order to provide better market alignment and to strengthen Akzo Nobel’s overall position in feed additives, Akzo Nobel has decided to consolidate the CRINA® and Bredol ...
|
|
19 Feb 2004
|
Intervet maintains course despite economic headwinds
Boxmeer, Netherlands, February 19, 2004 – With total sales in 2003 of EUR 1,010 million, Intervet is well positioned to maintain its No. 3 position in the global animal health market despite the economic ...
|
|
19 Feb 2004
|
Intervet maintains course despite economic headwinds (Dutch version)
Boxmeer, 19 februari 2004 - Met een totale omzet in 2003 van EUR 1.010 miljoen is Intervet goed in staat de nummer 3-positie op de wereldmarkt voor diergeneesmiddelen te handhaven, ondanks de economische ...
|
|
2 Feb 2004
|
Intervet provides support to authorities' efforts to halt the spread of bird flu in Asia
Boxmeer, the Netherlands, February 2, 2004 – Intervet, Akzo Nobel’s animal healthcare business, is providing local and international authorities support to combat the avian flu (Avian Influenza) epidemic ...
|
|
2 Feb 2004
|
Intervet provides support to authorities' efforts to halt the spread of bird flu in Asia (Dutch version)
Boxmeer, 2 februari 2004 – Intervet, het veterinair farmaceutisch bedrijf van Akzo Nobel, ondersteunt lokale overheden en regeringen in hun strijd tegen de vogelgriepepidemie die momenteel door Azië raast. ...
|
|
8 Dec 2003
|
All tools for emergency vaccination against Classical Swine Fever available after EU positively evaluates discriminatory antibody test". (Dutch version)
Boxmeer, 05 december 2003 De Permanente Commissie van de EU heeft begin deze maand het Besluit van de Commissie omtrent positieve beoordeling van een onderscheidende test voor klassieke varkenspest goedgekeurd. ...
|
|
8 Dec 2003
|
All tools for emergency vaccination against Classical Swine Fever available after EU positively evaluates discriminatory antibody test
Boxmeer, December 05, 2003 At the beginning of this month, the EU Standing Committee approved the EU Commission Decision on the positive evaluation of a discriminatory test for Classical Swine Fever (CSF). ...
|
|
2 Dec 2003
|
Akzo Nobel opens new biotech vaccines facility
Arnhem, the Netherlands, December 1, 2003 - Akzo Nobel officially opened its new biotech vaccines production facility in Boxmeer this afternoon. The opening ceremony was performed by Secretary-General ...
|
|
2 Dec 2003
|
Akzo Nobel opens new biotech vaccines facility (Dutch version)
Akzo Nobel opent nieuwe fabriek voor biotechnologische vaccins Arnhem, 1 december 2003 - Akzo Nobel heeft vanmiddag in Boxmeer een nieuwe fabriek geopend voor de productie van biotechnologische vaccins. ...
|
|
7 Nov 2003
|
Intervet plant veldproef in het kader van de ontwikkeling en registratie van een gecombineerd vaccin tegen pseudo-vogelpest
Boxmeer, 6 november 2003 - In verband met een uitspraak van de Raad van State (Nederland) over een beroep tegen een door Intervet geplande veldproef zijn in de afgelopen dagen verschillende artikelen ...
|
|
4 Nov 2003
|
Nobilis Salenvac T-vaccin wint prijs tijdens VIV Europe 2003 (Dutch version)
Boxmeer, 31oktober 2003 - Nobilis Salenvac T, het nieuwe vaccin van Intervet dat vermeerderingsdieren en leghennen beschermt tegen Salmonella-infecties, heeft de VIV-prijs in de categorie diergeneeskunde ...
|
|
31 Oct 2003
|
Nobilis Salenvac T vaccine receives award at VIV Europe 2003
Boxmeer, October 19, 2003 - Nobilis Salenvac T, Intervet’s new vaccine that provides excellent protection for breeder and layer birds against Salmonella infections has received the VIV award in the category ...
|
|
17 Oct 2003
|
Akzo Nobel earnings in line with expectations, outlook unchanged
Arnhem, the Netherlands, October 17, 2003 – Akzo Nobel, the international pharmaceuticals, coatings and chemicals company, reports third quarter net earnings of EUR 178 million, 23% below the third quarter ...
|
|
20 May 2003
|
Intervet donates flu vaccine
Hundreds of tropical birds in the Netherlands have been vaccinated against Avian influenza with the help of Akzo Nobel’s animal healthcare business, Intervet. An outbreak of the disease struck a number ...
|
|
11 Apr 2003
|
Bommeli Diagnostics launches New CHEKIT-APP-AppIV Test
Liebefeld-Bern, Switzerland -March 15, 2003- Bommeli Diagnostics, the diagnostic unit within Akzo Nobels veterinary business Intervet International bv today announced the launch of its new and improved ...
|
|
1 Apr 2003
|
Vaccination against Avian Influenza
Boxmeer, March 27, 2003 - The outbreak of Avian Influenza (fowl plague) in the Netherlands has sparked an ongoing debate about vaccination as an additional measure to control this viral disease. In principle, ...
|
|
1 Apr 2003
|
Vaccination against Avian Influenza (German version)
Impfung gegen GeflügelpestBoxmeer, 1. April 2003 - Seit Ausbruch der Geflügelpest in den Niederlanden wird über Impfungen als unterstützende Maßnahme bei der Bekämpfung dieser Viruskrankheit diskutiert. ...
|
|
31 Mar 2003
|
Vaccination against Avian Influenza (Dutch version)
Boxmeer, 27 maart 2003 - Sinds de uitbraak van aviaire influenza (vogelpest) in Nederland wordt er gediscussieerd over vaccinatie als een ondersteunende maatregel ter bestrijding van de vogelpest. Vaccinatie ...
|
|
13 Mar 2003
|
Intervet weathered market challenges in 2002 (Dutch version)
Intervet doorstaat marktuitdagingen in 2002Boxmeer, 7 maart 2003 – Dankzij zijn uitstekende mondiale dekking en het brede assortiment vee- en huisdierproducten is Intervet dit jaar goed in staat gebleken ...
|
|
13 Mar 2003
|
Intervet weathered market challenges in 2002
Boxmeer, March 07, 2003 – Intervet’s excellent global coverage and its broad range of products for farm and companion animals put the company in a stable position to weather the year’s dips in the veterinary ...
|
|
11 Mar 2003
|
Achtergrondinformatie uitbraak Aviaire Influenza (Dutch version)
Algemene achtergrondinformatie Boxmeer, 10 maart 2003 – Op 1 maart 2003 heeft de Nederlandse overheid alle transport en export van pluimvee en pluimveegerelateerde boerderijproducten verboden na een ...
|
|
11 Mar 2003
|
Akzo Nobel earnings slightly down; debt reduced by EUR 800 million
Arnhem, the Netherlands, February 11, 2003 – Akzo Nobel, the international pharmaceuticals, coatings and chemicals company, reports net earnings (1) in line with the outlook of EUR 892 million, slightly ...
|
|
11 Mar 2003
|
Background information on Avian Influenza outbreak (German version)
Allgemeine Hintergrundinformationen Boxmeer, 11. März 2003 – Am 1. März 2003 haben die niederländischen Behörden sämtliche Transporte sowie den Export von Geflügel und Geflügelprodukten wegen des Verdachts ...
|
|
6 Nov 2002
|
Akzo Nobel’s Pharma proactive on growth
Akzo Nobel’s Pharma businesses are taking active steps to turn around a current temporary slowing in performance and return to a path of stable growth in the future. Akzo Nobel’s Pharma group will continue ...
|
|
23 Oct 2002
|
Akzo Nobel 2002 third quarter net income 3% down; outlook confirmed
Akzo Nobel, the international pharmaceutical, coatings and chemicals company, today announced a third quarter net income of EUR 232 million, 3% below last year. The outlook for 2002 was confirmed.Highlights:· All ...
|
|
21 Apr 2002
|
Mycofarm Nederland bv fully integrated into Intervet Nederland BV
Mycofarm Nederland bv fully integrated into Intervet Nederland bvBoxmeer, 19 April 2002 – Mycofarm Nederland bv and Intervet Nederland bv, the two Dutch subsidiaries of Intervet International bv, will ...
|
|
21 Mar 2002
|
Intervet closes 2001 in excellent shape
In 2001, Intervet placed a stronger focus on strengthening its presence in key country markets, notably the United States. With approximately 46 percent of the sales, Europe, the home market of Intervet, ...
|
|
22 Feb 2002
|
Resilient mix of businesses protects Akzo Nobel earnings
The net result1 for the fourth quarter exceeded the previous year’s figure by 3%. Pharma’s and Coatings’ ongoing operations closed higher. Pharma especially benefited from higher sales, while for Coatings ...
|
|
21 Nov 2001
|
Award of ‘Pettenkofer-Foundation’ presented to Dr. Teshome Mebatsion
Mid of November Dr. Teshome Mebatsion of Intervet International, Virology R&D received in Munich the Pettenkofer Prize 2001.This prize is presented every two years to scientists who perform outstanding ...
|
|
11 Oct 2001
|
Product news FMD Marker
Intervet announces FMD marker test Intervet, Akzo Nobel’s animal healthcare business, has developed a test for Foot and Mouth Disease (FMD) to indicate virus infection in vaccinated animals. The ...
|
|
21 Mar 2001
|
Akzo Nobel appoints new manager for its business unit Intervet
Ruurd Stolp, who holds a PhD in Veterinary Medicine from University of Utrecht, joined Intervet in 1989 as Head, Microbiological Quality Control. Following his return in 1996 from a post with Intervet’s ...
|
About Us